Advocacy

ACTA negotiates and advocates on behalf of the clinical trials sector with governments, health care policymakers and consumers on issues that impact the conduct of investigator-initiated clinical trials across the Australian health system.

Greater engagement and partnership between policymakers and clinical researchers significantly improves the process of generating high-quality evidence for new and existing clinical therapies at low marginal cost or with cost-savings.

ACTA represents the sector across many National and International Committees.  At this time, these include:

• Clinical Trials – Phase 2 Advisory Committee (Advisory Committee): working with the Australian Commission on Safety and Quality in Health Care on the development and pilot of the National Clinical Trials Governance Framework.